Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study

Abstract Purpose Ovarian cancer is the most common cause of gynecologic cancer-related deaths. We aimed to assess the global, regional, and national burdens and trends of Ovarian Cancer in Women Aged 45 + from 1990 to 2019 and Projections for 2050, utilizing data from the most recent Global Burden o...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanan Ren, Ren Xu, Yazhuo Wang, LuYang Su, Jianzhi Su
Format: Article
Language:English
Published: Springer 2025-08-01
Series:Journal of Cancer Research and Clinical Oncology
Subjects:
Online Access:https://doi.org/10.1007/s00432-025-06277-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238095533178880
author Yanan Ren
Ren Xu
Yazhuo Wang
LuYang Su
Jianzhi Su
author_facet Yanan Ren
Ren Xu
Yazhuo Wang
LuYang Su
Jianzhi Su
author_sort Yanan Ren
collection DOAJ
description Abstract Purpose Ovarian cancer is the most common cause of gynecologic cancer-related deaths. We aimed to assess the global, regional, and national burdens and trends of Ovarian Cancer in Women Aged 45 + from 1990 to 2019 and Projections for 2050, utilizing data from the most recent Global Burden of Disease (GBD) 2021 database. Methods Age-standardized rates of incidence, prevalence, mortality, and disability-adjusted life years (DALYs) were analyzed using GBD 2021 data. Temporal trends were assessed using estimated annual percentage change (EAPC). Regional disparities were examined via the Socio-Demographic Index (SDI). Age-Period-Cohort (APC) models assessed disease dynamics, while Bayesian APC (BAPC) modeling projected trends to 2050. Results In 2021, global ovarian cancer incidence, prevalence, mortality, and DALYs in women aged 45 + were 239,682; 843,405; 171,246; and 4,352,539, respectively. The global burden declined significantly from 1990 to 2021 and is projected to remain stable through 2050. However, regional disparities persist: High and High-middle SDI regions saw decreases, while Middle to Low SDI regions experienced increases. Burden increased with SDI up to 0.8, then declined. Population growth was the primary contributor, followed by epidemiologic transitions and aging. The 55–59 age group showed the highest morbidity and DALYs; mortality peaked at 65–69 years. Conclusions Although the overall burden of ovarian cancer in women aged 45 + is declining globally, marked regional disparities underscore the need for tailored prevention and treatment strategies to further reduce disease impact and improve outcomes.
format Article
id doaj-art-7022825edcd64b918c7ae583e8f69a0c
institution Kabale University
issn 1432-1335
language English
publishDate 2025-08-01
publisher Springer
record_format Article
series Journal of Cancer Research and Clinical Oncology
spelling doaj-art-7022825edcd64b918c7ae583e8f69a0c2025-08-20T04:01:46ZengSpringerJournal of Cancer Research and Clinical Oncology1432-13352025-08-01151811510.1007/s00432-025-06277-9Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease studyYanan Ren0Ren Xu1Yazhuo Wang2LuYang Su3Jianzhi Su4Department of Obstetrics and Gynecology, Hebei General HospitalDepartment of Obstetrics and Gynecology, Hebei General HospitalDepartment of Obstetrics and Gynecology, Hebei General HospitalPhysical Examination Center, Hebei General HospitalDepartment of Urology Surgery, The Fourth Hospital of Hebei Medical UniversityAbstract Purpose Ovarian cancer is the most common cause of gynecologic cancer-related deaths. We aimed to assess the global, regional, and national burdens and trends of Ovarian Cancer in Women Aged 45 + from 1990 to 2019 and Projections for 2050, utilizing data from the most recent Global Burden of Disease (GBD) 2021 database. Methods Age-standardized rates of incidence, prevalence, mortality, and disability-adjusted life years (DALYs) were analyzed using GBD 2021 data. Temporal trends were assessed using estimated annual percentage change (EAPC). Regional disparities were examined via the Socio-Demographic Index (SDI). Age-Period-Cohort (APC) models assessed disease dynamics, while Bayesian APC (BAPC) modeling projected trends to 2050. Results In 2021, global ovarian cancer incidence, prevalence, mortality, and DALYs in women aged 45 + were 239,682; 843,405; 171,246; and 4,352,539, respectively. The global burden declined significantly from 1990 to 2021 and is projected to remain stable through 2050. However, regional disparities persist: High and High-middle SDI regions saw decreases, while Middle to Low SDI regions experienced increases. Burden increased with SDI up to 0.8, then declined. Population growth was the primary contributor, followed by epidemiologic transitions and aging. The 55–59 age group showed the highest morbidity and DALYs; mortality peaked at 65–69 years. Conclusions Although the overall burden of ovarian cancer in women aged 45 + is declining globally, marked regional disparities underscore the need for tailored prevention and treatment strategies to further reduce disease impact and improve outcomes.https://doi.org/10.1007/s00432-025-06277-9Ovarian cancerGlobal burden of diseaseSocio-demographic indexAge-period-cohort modelBayesian age-period-cohort projectionsIncidence
spellingShingle Yanan Ren
Ren Xu
Yazhuo Wang
LuYang Su
Jianzhi Su
Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study
Journal of Cancer Research and Clinical Oncology
Ovarian cancer
Global burden of disease
Socio-demographic index
Age-period-cohort model
Bayesian age-period-cohort projections
Incidence
title Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study
title_full Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study
title_fullStr Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study
title_full_unstemmed Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study
title_short Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study
title_sort global regional and national burden of ovarian cancer in women aged 45 from 1990 to 2021 and projections for 2050 a systematic analysis based on the 2021 global burden of disease study
topic Ovarian cancer
Global burden of disease
Socio-demographic index
Age-period-cohort model
Bayesian age-period-cohort projections
Incidence
url https://doi.org/10.1007/s00432-025-06277-9
work_keys_str_mv AT yananren globalregionalandnationalburdenofovariancancerinwomenaged45from1990to2021andprojectionsfor2050asystematicanalysisbasedonthe2021globalburdenofdiseasestudy
AT renxu globalregionalandnationalburdenofovariancancerinwomenaged45from1990to2021andprojectionsfor2050asystematicanalysisbasedonthe2021globalburdenofdiseasestudy
AT yazhuowang globalregionalandnationalburdenofovariancancerinwomenaged45from1990to2021andprojectionsfor2050asystematicanalysisbasedonthe2021globalburdenofdiseasestudy
AT luyangsu globalregionalandnationalburdenofovariancancerinwomenaged45from1990to2021andprojectionsfor2050asystematicanalysisbasedonthe2021globalburdenofdiseasestudy
AT jianzhisu globalregionalandnationalburdenofovariancancerinwomenaged45from1990to2021andprojectionsfor2050asystematicanalysisbasedonthe2021globalburdenofdiseasestudy